ERGENÇ, İ. Et Al. 2023. The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients. Hepatology forum , vol.4, no.2 , 69-73.

ERGENÇ, İ., Gozaydinoglu, B., KEKLİKKİRAN, C., & YILMAZ, Y., (2023). The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients. Hepatology forum , vol.4, no.2, 69-73.

ERGENÇ, İlkay Et Al. "The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients," Hepatology forum , vol.4, no.2, 69-73, 2023

ERGENÇ, İlkay Et Al. "The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients." Hepatology forum , vol.4, no.2, pp.69-73, 2023

ERGENÇ, İ. Et Al. (2023) . "The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients." Hepatology forum , vol.4, no.2, pp.69-73.

@article{article, author={İlkay ERGENÇ Et Al. }, title={The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients}, journal={Hepatology forum}, year=2023, pages={69-73} }